Creative Medical Technology Holdings Inc
CELZ2.220USD
+0.050+2.30%
收盤 12/24, 13:00（美東）報價延遲15分鐘
5.73M總市值
虧損本益比TTM
關於 Creative Medical Technology Holdings Inc 公司
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Creative Medical Technology Holdings Inc簡介
公司代碼CELZ
公司名稱Creative Medical Technology Holdings Inc
上市日期May 01, 2009
CEOWarbington (Timothy)
員工數量4
證券類型Ordinary Share
年結日May 01
公司地址211 E. Osborn Rd.
城市PHOENIX
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編85012
電話14803992822
網址https://creativemedicaltechnology.com/
公司代碼CELZ
上市日期May 01, 2009
CEOWarbington (Timothy)
Creative Medical Technology Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 12月14日 週日
更新時間: 12月14日 週日
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
0.74%
Geode Capital Management, L.L.C.
0.67%
Creative Medical Health, Inc.
0.65%
DRW Securities, LLC
0.43%
Warbington (Timothy)
0.35%
其他
97.16%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
0.74%
Geode Capital Management, L.L.C.
0.67%
Creative Medical Health, Inc.
0.65%
DRW Securities, LLC
0.43%
Warbington (Timothy)
0.35%
其他
97.16%
股東類型
持股股東
佔比
Investment Advisor
1.37%
Investment Advisor/Hedge Fund
0.67%
Corporation
0.65%
Individual Investor
0.48%
Research Firm
0.03%
其他
96.80%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
27
72.58K
11.84%
--
2025Q3
29
72.58K
11.88%
+776.00
2025Q2
25
71.80K
10.72%
-129.79K
2025Q1
23
201.59K
4.41%
+89.66K
2024Q4
25
29.86K
7.67%
-49.38K
2024Q3
28
77.15K
11.92%
-653.00
2024Q2
30
77.93K
20.77%
-35.91K
2024Q1
32
113.90K
14.79%
-86.68K
2023Q4
34
27.41K
16.84%
+6.21K
2023Q3
38
90.73K
17.10%
+463.00
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
17.63K
0.68%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
20.88K
0.81%
+2.61K
+14.28%
Jun 30, 2025
Creative Medical Health, Inc.
22.70K
0.88%
--
--
Apr 15, 2025
Warbington (Timothy)
12.21K
0.47%
--
--
Apr 15, 2025
Allworth Financial, L.P.
4.00K
0.15%
+4.00K
--
Jun 30, 2025
Osaic Holdings, Inc.
1.13K
0.04%
-131.00
-10.39%
Jun 30, 2025
Finger (Michael H.)
351.00
0.01%
-1.50K
-81.04%
Apr 15, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
公告日期
類型
比率
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
常見問題
Creative Medical Technology Holdings Inc的前五大股東是誰？
Creative Medical Technology Holdings Inc的前五大股東如下：
The Vanguard Group, Inc.持有股份：17.63K佔總股份比例：0.68%。
Geode Capital Management, L.L.C.持有股份：20.88K佔總股份比例：0.81%。
Creative Medical Health, Inc.持有股份：22.70K佔總股份比例：0.88%。
Warbington (Timothy)持有股份：12.21K佔總股份比例：0.47%。
Allworth Financial, L.P.持有股份：4.00K佔總股份比例：0.15%。
The Vanguard Group, Inc.持有股份：17.63K佔總股份比例：0.68%。
Geode Capital Management, L.L.C.持有股份：20.88K佔總股份比例：0.81%。
Creative Medical Health, Inc.持有股份：22.70K佔總股份比例：0.88%。
Warbington (Timothy)持有股份：12.21K佔總股份比例：0.47%。
Allworth Financial, L.P.持有股份：4.00K佔總股份比例：0.15%。
Creative Medical Technology Holdings Inc的前三大股東類型是什麼？
Creative Medical Technology Holdings Inc 的前三大股東類型分別是：
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Creative Medical Health, Inc.
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Creative Medical Health, Inc.
有多少機構持有Creative Medical Technology Holdings Inc(CELZ)的股份？
截至2025Q4，共有27家機構持有Creative Medical Technology Holdings Inc的股份，合計持有的股份價值約為72.58K，占公司總股份的11.84% 。與2025Q3相比，機構持股有所增加，增幅為-0.04%。
哪個業務部門對Creative Medical Technology Holdings Inc的收入貢獻最大？
在--，--業務部門對Creative Medical Technology Holdings Inc的收入貢獻最大，創收--，占總收入的--% 。
